dropopizine

Dropopizine is a peripheral antitussive agent used for the symptomatic treatment of non-productive (dry) cough. It is the racemic mixture of levodropropizine and dextrodropropizine. Unlike opioid-based cough suppressants such as codeine, dropopizine acts primarily on the peripheral cough receptors in the respiratory tract rather than the central nervous system. This peripheral mechanism of action helps to avoid common side effects associated with central antitussives, such as sedation, respiratory depression, and potential for dependency. It is marketed in several European and Latin American countries, with Robugen being a notable developer and manufacturer in Germany, where it is sold under the brand name Larylin.

Brand names

LarylinCatabexTussiflex

Other names

dropopizindropopizinaracemic dropopizine